COMPARATIVE EFFECTIVENESS OF DELAYED-RELEASE DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE ON RISK OF RELAPSE

被引：0
|
作者：
Nicholas, Jacqueline [1 ]
Boster, Aaron [1 ]
Wu, Ning [2 ]
Huang, Ming-Yi [2 ]
Riester, Katherine [2 ]
Jhaveri, Mehul [2 ]
Edwards, Michael [2 ]
Lee, Andrew [2 ]
机构：
[1] OhioHlth Multiple Sclerosis Ctr, Columbus, OH USA
[2] Biogen, Cambridge, MA USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.375
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry
    Braune, Stefan
    Grimm, Sarah
    van Hoevell, Philip
    Freudensprung, Ulrich
    Pellegrini, Fabio
    Hyde, Robert
    Bergmann, Arnfin
    JOURNAL OF NEUROLOGY, 2018, 265 (12) : 2980 - 2992
  • [2] Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry
    Stefan Braune
    Sarah Grimm
    Philip van Hövell
    Ulrich Freudensprung
    Fabio Pellegrini
    Robert Hyde
    Arnfin Bergmann
    Journal of Neurology, 2018, 265 : 2980 - 2992
  • [3] Comparative Effectiveness of Dimethyl Fumarate Versus Fingolimod and Teriflunomide on the Risk of Relapse in MS Patients Switching from First-Generation Platform Therapies in the US
    Nicholas, Jacqueline
    Carraro, Matthew
    Ontaneda, Daniel
    Zhou, Jia
    Hou, Qiang
    Babb, Jaanai
    Riester, Katherine
    Mendoza, Jason
    Livingston, Terrie
    Jhaveri, Mehul
    NEUROLOGY, 2018, 90
  • [4] Multiple sclerosis relapse-related costs of oral disease-modifying therapies in Denmark: an economic analysis comparing delayed-release dimethyl fumarate, fingolimod and teriflunomide
    O'malley, P.
    Lee, A.
    O'day, K.
    Friedman, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 543 - 543
  • [5] Leveraging Real-World Evidence for Comparative Effectiveness: Delayed-Release Dimethyl Fumarate Vs. Fingolimod and Glatiramer Acetate in RRMS
    Min, Jinny
    Sloane, Jacob
    Phillips, J. Theodore
    Chan, Andrew
    Cohan, Stanley
    Alvarez, Enrique
    Okwuokenye, Macaulay
    Taylor, Catherine
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 17 - 18
  • [6] Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis
    Fox, Robert J.
    Chan, Andrew
    Zhang, Annie
    Xiao, James
    Levison, Dane
    Lewin, James B.
    Edwards, Michael R.
    Marantz, Jing L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (02) : 175 - 183
  • [7] DELAYED-RELEASE DIMETHYL FUMARATE-ASSOCIATED LYMPHOPENIA
    Chan, Andrew
    Fox, Robert J.
    Bar-Or, Amit
    Chen, Chongshu
    Fam, Sami
    Gold, Ralf
    Hanna, Jerome
    Mehta, Devangi
    Phillips, J. Theodore
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E53 - E53
  • [8] Delayed-release dimethyl fumarate significantly reduced relapse based outcomes vs. interferon, glatiramer acetate, or teriflunomide: pairwise propensity-matched comparative effectiveness analyses of the German NeuroTransData registry
    Braune, S.
    Grimm, S.
    van Hoevell, P.
    Freudensprung, U.
    Hyde, R.
    Bergmann, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 856 - 856
  • [9] Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study
    Kalincik, T.
    Spelman, T.
    Jokubaitis, V.
    Horakova, D.
    Havrdova, E.
    Izquierdo, G.
    Prat, A.
    Girard, M.
    Duquette, P.
    Lugaresi, A.
    Grammond, P.
    Alroughani, R.
    Lechner-Scott, J.
    Prevost, J.
    Terzi, M.
    Grand'Maison, F.
    Boz, C.
    Trojano, M.
    Van Wijmeersch, B.
    Pucci, E.
    Granella, F.
    Turkoglu, R.
    Sola, P.
    Ferraro, D.
    McCombe, P.
    Solaro, C.
    Van Pesch, V.
    Ozakbas, S.
    Slee, M.
    Spitaleri, D.
    Sanchez-Menoyo, J. L.
    Ampapa, R.
    Hodgkinson, S.
    Karabudak, R.
    Vucic, S.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 325 - 327
  • [10] THE COST EFFECTIVENESS OF DELAYED-RELEASE DIMETHYL FUMARATE VERSUS INTERFERON BETA-1B IN A SWEDISH SETTING
    Granfeldt, D.
    Bjorstad, A.
    Ohrman, S.
    Bjorholt, I
    VALUE IN HEALTH, 2015, 18 (07) : A757 - A757
12345